Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Weitz

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 25, 2013
Extended treatment of venous thromboembolismJeffrey Weitz
Seminars in Vascular Medicine|June 17, 2004
Orally active direct thrombin inhibitorsJeffrey Weitz
Annals of Internal Medicine|August 15, 2017
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleedingNoel Chan, Jeffrey Weitz
Thrombosis Research|May 4, 2010
Role of the tissue factor pathway in the biology of tumor initiating cellsDelphine Garnier, Chloe Milsom, Nathalie Magnus, et al.
Circulation|July 10, 2002
Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis preventionAnthony K C Chan, Janusz Rak, Leslie Berry, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2019
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer studyMarcello Di Nisio, Nick van Es, Marc Carrier, et al.
Kidney International Reports|February 14, 2022
Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXI<sub>Rx</sub> in Patients With ESRDMichael Walsh, Claudette Bethune, Andrew Smyth, et al.
Thrombosis Research|February 5, 2003
Low-dose warfarin in rehabilitating stroke survivorsJeffrey S Ginsberg, Shannon M Bates, Wieslaw Oczkowski, et al.
European Heart Journal|April 12, 2007
Anticoagulants in heart disease: current status and perspectivesRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Annals of Emergency Medicine|July 4, 2017
Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency CareRichard C Dart, Lewis R Goldfrank, Brian L Erstad, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Advances in Hematology & Oncology : H&O|July 25, 2013
Extended treatment of venous thromboembolismJeffrey Weitz
Seminars in Vascular Medicine|June 17, 2004
Orally active direct thrombin inhibitorsJeffrey Weitz
Annals of Internal Medicine|August 15, 2017
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleedingNoel Chan, Jeffrey Weitz
Thrombosis Research|May 4, 2010
Role of the tissue factor pathway in the biology of tumor initiating cellsDelphine Garnier, Chloe Milsom, Nathalie Magnus, et al.
Circulation|July 10, 2002
Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis preventionAnthony K C Chan, Janusz Rak, Leslie Berry, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2019
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer studyMarcello Di Nisio, Nick van Es, Marc Carrier, et al.
Kidney International Reports|February 14, 2022
Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXI<sub>Rx</sub> in Patients With ESRDMichael Walsh, Claudette Bethune, Andrew Smyth, et al.
Thrombosis Research|February 5, 2003
Low-dose warfarin in rehabilitating stroke survivorsJeffrey S Ginsberg, Shannon M Bates, Wieslaw Oczkowski, et al.
European Heart Journal|April 12, 2007
Anticoagulants in heart disease: current status and perspectivesRaffaele De Caterina, Steen Husted, Lars Wallentin, et al.
Annals of Emergency Medicine|July 4, 2017
Expert Consensus Guidelines for Stocking of Antidotes in Hospitals That Provide Emergency CareRichard C Dart, Lewis R Goldfrank, Brian L Erstad, et al.
Pageof 2